CN Patent

CN105106105A — 噻吗洛尔外用制剂治疗婴幼儿血管瘤的应用及其制备方法

Assigned to Tianjin City Juxing Kanghua Medical Science & Technology Co Ltd · Expires 2015-12-02 · 10y expired

What this patent protects

本发明公开了噻吗洛尔外用制剂治疗婴幼儿血管瘤的应用及其制备方法，属于药学领域。本发明的主要目的是提供多种可供外用的噻吗洛尔制剂，用于治疗婴幼儿血管瘤。通过加入适宜的辅料，如：凝胶基质、经皮促渗剂、防腐剂、保湿剂、乳化剂、成膜材料、油性基质等，本发明可制成多种外用制剂，如：凝胶剂、涂膜剂、膏剂、涂剂等。本发明涉及的噻吗洛尔外用制剂具有安全性高、疗效确切、耐受良好、起效迅速等特点。

USPTO Abstract

本发明公开了噻吗洛尔外用制剂治疗婴幼儿血管瘤的应用及其制备方法，属于药学领域。本发明的主要目的是提供多种可供外用的噻吗洛尔制剂，用于治疗婴幼儿血管瘤。通过加入适宜的辅料，如：凝胶基质、经皮促渗剂、防腐剂、保湿剂、乳化剂、成膜材料、油性基质等，本发明可制成多种外用制剂，如：凝胶剂、涂膜剂、膏剂、涂剂等。本发明涉及的噻吗洛尔外用制剂具有安全性高、疗效确切、耐受良好、起效迅速等特点。

Drugs covered by this patent

propranolol-hydrochloride (PROPRANOLOL HYDROCHLORIDE)

Patent Metadata

Patent number: CN105106105A
Jurisdiction: CN
Classification: —
Expires: 2015-12-02
Drug substance claim: No
Drug product claim: No
Assignee: Tianjin City Juxing Kanghua Medical Science & Technology Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.